Riluzole

IUPAC name

6-(trifluoromethoxy)-1,3-benzothiazol-2-amine

CAS No.

1744-22-5

Molecular Weight

234.20 g·mol−1

Molecular Formula

C8H5F3N2OS

 

 

Mechanism Of Action:

The mode of action is unknown; it’s believe that it has inhibitory effect on glutamate release (activation of glutamate reuptake), and inactivity effect on voltage-dependent sodium channels, and also ability to interfere with intracellular events that follow transmitter binding at excitatory amino acid receptors.
 

Indication:

Riluzole is indicated for the treatment of patients with amyotrophic lateral sclerosis (ALS).